Retraction statement: Luo L, Liu H and Xi Q (2018) Trastuzumab induces PUMA-dependent apoptosis and inhibits tumor growth in gastric cancer. FEBS Open Bio 8, 1911-1919.

Abstract

FEBS Open BioEarly View Retraction NoticeOpen Access Retraction statement: Luo L, Liu H and Xi Q (2018) Trastuzumab induces PUMA-dependent apoptosis and inhibits tumor growth in gastric cancer. FEBS Open Bio 8, 1911–1919. This article retracts the following: Retracted: Trastuzumab induces PUMA-dependent apoptosis and inhibits tumor growth in gastric cancer Linghe Luo, Haiyan Liu, Qian Xi, Volume 8Issue 12FEBS Open Bio pages: 1911-1919 First Published online: November 19, 2018 First published: 17 March 2023 https://doi.org/10.1002/2211-5463.13587AboutSectionsPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat https://doi.org/10.1002/2211-5463.12522 The above article, published online on 15 September 2018 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the Editor-in-Chief, FEBS Press, and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications between this and other published articles [[1-4]]. Thus, the editors consider the conclusions of this manuscript substantially compromised. References 1Wang X, Xue Q, Wu L, Wang B and Liang H (2018) Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer. FEBS Open Bio 8, 732– 742. 2Chen G, Chen Z and Zhao H (2020) MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1. J Cell Mol Med 24, 5363– 5374. 3Tian T, Guo T, Zhen W, Zou J and Li F (2020) BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells. Cell Death Dis 11, 900. 4Qu H, Song X, Song Z, Jiang X, Gao X, Bai L, Wu J, Na L and Yao Z (2020) Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma. Cancer Cell Int 20, 592. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation